As digital health technologies become embedded in clinical research and decentralized clinical trials, regulatory expectations are evolving alongside them.
For remote patient monitoring (RPM) devices that have become a core part of trials, this means that focus now includes the way data is collected, transmitted, processed, and stored. For digital health technologies to continue being effective, traceability and compliance must be included from the outset. Essentially, they need to be audit-ready by design.
Traceability isn’t something you treat as an afterthought, or simply an add-on compliance feature. It’s important for sponsors to be aware of the additional layers that advanced third-party technologies can add to the regulatory process, especially as these technologies grow more common. Using devices without fully understanding how they collect, transmit, and store data can make it difficult to stay compliant, and sometimes the extent of the knowledge gap may not be clear until an audit actually takes place.
At Vivalink, our platform is purpose-built to enable continuous, end-to-end data traceability without adding operational burdens for sponsors or trial teams. This approach allows sponsors to move faster, approach audits with regulatory confidence, and avoid compliance issues down the line that could delay validation.
In this blog, we will cover:
Ensuring regulatory compliance is a critical step in designing audit-ready devices. In the United States, 21 CFR Part 11 requires that systems must maintain traceability and integrity if data is managed electronically. In order to ensure compliance for most digital health devices, regulations require secure user authentication, role-based access controls, and audit trails that document when data is created, reviewed, or changed.
Meeting these requirements can be a challenge for those using third-party devices. If the full scope of technology being used is not shared, you run the risk of being unable to meet these rules. Sponsors might not even find out that the device is not compliant until an audit, which can result in potential penalties that endanger trials. It’s crucial to have that transparency in place from the start, which is why we prioritize compliance in our own device design.
One of the most common audit risks in digital trials arises from fragmented systems, which can make it difficult for trial teams to trust their own data. When data flows through disconnected platforms, clinicians are often forced to manually download, reformat, and re-upload files. Each manual step introduces the potential for human error, data loss, or undocumented changes. By designing devices to enable an automated data flow from the original source instead, we can ensure that data lineage is preserved, allowing the trial to progress efficiently.
To meet regulation requirements, medical-grade digital health tools must provide clear insight into how raw signals are captured and processed. Without this insight, sponsors and regulators cannot verify data quality and analytical methods. This risk also extends to patient privacy and data security. Regulations such as HIPAA and GDPR require that digital health systems provide comprehensive privacy protection when collecting, storing, or sharing sensitive health information. Devices without this protection built in run the risk of penalties from $100 to $50,000 per violation, depending on the level of negligence. Altogether, these risks can threaten an entire trial.
Audit-ready digital health tools minimize these risks. At Vivalink, we put this in action by centralizing device data management, audit trails, and compliance controls in a single, validated environment. Instead of leaving sponsors and trials teams scrambling to reconstruct how data moved through multiple systems, this provides the documentation and transparency to respond to audits quickly and smoothly, ensuring that trials remain uninterrupted.
An audit-ready digital health tool removes unnecessary manual intervention, ensures data traceability from sensor to database, and provides full transparency into how data is generated and managed. At Vivalink, we’ve seen that embedding compliance, interoperability, and security into system design reduces audit risk for sponsors and trial teams, all while strengthening the scientific integrity of their trials. Explore how we’re already supporting compliant devices in modern clinical trials.
Copyright © 2026 VivaLNK, Inc. All Rights Reserved.
No Comments Yet
Let us know what you think